Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (161-170 of 290) with videos related to

Pageof 29
Sort By:
Crohn'S & Colitis 360|April 24, 2026
Efficacy and safety of ABBV-154 in patients with moderately to severely active Crohn's disease: a phase 2b, randomized, double-blind, placebo-controlled trialWalter Reinisch, Laurent Peyrin-Biroulet, Geert D'Haens, et al.
Talanta|August 6, 2010
Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysisMuriel De Bock, Dominique de Seny, Marie-Alice Meuwis, et al.
Journal of Crohn'S & Colitis|December 3, 2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosisGert Van Assche, Axel Dignass, Julian Panes, et al.
Maedica|August 17, 2023
Impact of Dietary Patterns in Inflammatory Bowel Disease Subtypes <i>Versus</i> Healthy Subjects: a Retrospective Cohort StudyCarmen Monica Preda, Doina Istratescu, Maria Nitescu, et al.
Annals of the Rheumatic Diseases|March 3, 2011
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritisDominique de Seny, Mohammed Sharif, Marianne Fillet, et al.
Frontiers in Microbiology|May 16, 2022
Association Between Human Gut Microbiome and N-Glycan Composition of Total Plasma ProteomeVyacheslav A Petrov, Sodbo Zh Sharapov, Lev Shagam, et al.
Molecular Cancer|August 31, 2013
Cancer risk in immune-mediated inflammatory diseases (IMID)Rudi Beyaert, Laurent Beaugerie, Gert Van Assche, et al.
Nature Communications|April 28, 2026
Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trialPerle Guarino-Vignon, Edouard Louis, Hang-Phuong Pham, et al.
Inflammatory Bowel Diseases|March 30, 2021
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel DiseasesClaire Liefferinckx, Jérémie Bottieau, Jean-François Toubeau, et al.
Human Molecular Genetics|September 21, 2007
An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseasesVinciane Dideberg, Gudlaug Kristjansdottir, Lili Milani, et al.
Pageof 29

Showing results (161-170 of 290) with videos related to

Sort By:
Pageof 29
Crohn'S & Colitis 360|April 24, 2026
Efficacy and safety of ABBV-154 in patients with moderately to severely active Crohn's disease: a phase 2b, randomized, double-blind, placebo-controlled trialWalter Reinisch, Laurent Peyrin-Biroulet, Geert D'Haens, et al.
Talanta|August 6, 2010
Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysisMuriel De Bock, Dominique de Seny, Marie-Alice Meuwis, et al.
Journal of Crohn'S & Colitis|December 3, 2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosisGert Van Assche, Axel Dignass, Julian Panes, et al.
Maedica|August 17, 2023
Impact of Dietary Patterns in Inflammatory Bowel Disease Subtypes <i>Versus</i> Healthy Subjects: a Retrospective Cohort StudyCarmen Monica Preda, Doina Istratescu, Maria Nitescu, et al.
Annals of the Rheumatic Diseases|March 3, 2011
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritisDominique de Seny, Mohammed Sharif, Marianne Fillet, et al.
Frontiers in Microbiology|May 16, 2022
Association Between Human Gut Microbiome and N-Glycan Composition of Total Plasma ProteomeVyacheslav A Petrov, Sodbo Zh Sharapov, Lev Shagam, et al.
Molecular Cancer|August 31, 2013
Cancer risk in immune-mediated inflammatory diseases (IMID)Rudi Beyaert, Laurent Beaugerie, Gert Van Assche, et al.
Nature Communications|April 28, 2026
Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trialPerle Guarino-Vignon, Edouard Louis, Hang-Phuong Pham, et al.
Inflammatory Bowel Diseases|March 30, 2021
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel DiseasesClaire Liefferinckx, Jérémie Bottieau, Jean-François Toubeau, et al.
Human Molecular Genetics|September 21, 2007
An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseasesVinciane Dideberg, Gudlaug Kristjansdottir, Lili Milani, et al.
Pageof 29